[1]
S. M. Al-Qahtani, G. Bryzgalova, S. Efendić, P.-O. Berggren, and N. Portwood, “Activation of hepatic AMPK by 17β-estradiol suppresses both nuclear receptor Nr2c2/TR4 and its downstream lipogenic targets, reduces gluconeogenic genes and improves insulin signaling”, dmm, vol. 4, no. 4, pp. 55-67, Dec. 2016.